Showing results (1601-1610 of 1,614) with videos related to

Sort By:
Pageof 162
RSC Medicinal Chemistry|September 3, 2026
Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunitiesSahar Salem, Rania Hamdy, Sarra B Shakartalla, et al.
RSC Medicinal Chemistry|September 15, 2026
Design, synthesis, and biological evaluation of novel coumarin-derived as oral SERDs with favorable bioavailabilityShiyun Chen, Mengyu Chen, Xiongxiang Huang, et al.
RSC Medicinal Chemistry|September 15, 2026
Pyrimidine- and furo[2,3-d]pyrimidine-isoxazole hybrids and their Re(i) tricarbonyl complexes with antiproliferative activity against hematological malignanciesMartina Piškor Benković, Ivan Ćorić, Leon Sačer, et al.
RSC Medicinal Chemistry|September 19, 2026
Synthesis and evaluation of novel 3,5-dinitrobenzoyl substituted amino acid hydrazides against Mycobacterium tuberculosisFatimah M Alsalem, Alistair K Brown, Andrew K Crowhurst, et al.
RSC Medicinal Chemistry|October 2, 2026
Strategic synthesis, antibacterial evaluation and SAR analysis of bisindole-chromone hybrids as an anti-staphylococcal agentArti Rathore, Rohit Singh, Biplab Sarkar, et al.
RSC Medicinal Chemistry|October 2, 2026
Design and synthesis of carbazole-acrylamide-pyridinium hybrids as dual acetylcholinesterase/butyrylcholinesterase inhibitors and evaluation of their cytotoxic profile on SH-SY5Y and HEK293 cell linesAmir Mohammad Taherkhani, Halil Şenol, Yousef Valizadeh, et al.
RSC Medicinal Chemistry|October 3, 2026
Improving the metabolic stability of a selective mTOR inhibitor through scaffold deconstruction and carbamate explorationÁlvaro Lorente-Macías, Jonathon Mok, Margaret C Frame, et al.
RSC Medicinal Chemistry|October 20, 2026
Targeting PRMT3 for therapeutic intervention: underlying mechanisms and translational perspectivesZiqiang Hu, Qi Ma, Yumeng Xu, et al.
RSC Medicinal Chemistry|October 20, 2026
First demonstration of benzosultam CRBN ligand-mediated PROTACs for BTK and BRD4 degradationHoyeong Park, Moonjung Jeun, Ji U Choi, et al.
RSC Medicinal Chemistry|October 20, 2026
Pan-cancer analysis reveals DNAJC9 as an immune-related biomarker and a positive regulator of the PI3K/AKT signaling pathwayZihao Li, Yiwen Wu, Jiayi Li, et al.
Pageof 162